Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease

Utriainen Karri T., Airaksinen Juhani K., Polo Olli, Raitakari Olli T., Pietilä Mikko J., Scheinin Harry, Helenius Hans Y., Leino Kari A., Kentala Erkki S., Jalonen Jouko R., Hakovirta Harri, Salo Tiina M., Laitio Timo T.

Source: Eur Respir J 2013; 41: 616-620
Journal Issue: March
Disease area: Pulmonary vascular diseases, Sleep and breathing disorders

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Utriainen Karri T., Airaksinen Juhani K., Polo Olli, Raitakari Olli T., Pietilä Mikko J., Scheinin Harry, Helenius Hans Y., Leino Kari A., Kentala Erkki S., Jalonen Jouko R., Hakovirta Harri, Salo Tiina M., Laitio Timo T.. Unrecognised obstructive sleep apnoea is common in severe peripheral arterial disease. Eur Respir J 2013; 41: 616-620

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Incidence of cardiovascular complications in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Sleep apnoea in cardiorespiratory disorders
Year: 2007


Unrecognised systemic hypertension in patients with obstructive sleep apnoea
Source: Eur Respir J 2006; 28: Suppl. 50, 643s
Year: 2006

Metabolic disturbances in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2010 - Clinical aspects of sleep apnoea
Year: 2010

Chronic obstructive pulmonary disease in patients with obstructive sleep apnea
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009

Cardiac arrythmias in chronic obstructive pulmonary disease and obstructive sleep apnoea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 645s
Year: 2006

Obstructive sleep apnoea and COPD
Source: Eur Respir Mon 2013; 59: 135-143
Year: 2013


Prevalence of obstructive airway disease in patients with obstructive sleep apnea
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012

Undiagnosed COPD and overlapping obstructive sleep apnoea in coronary heart disease
Source: International Congress 2017 – Primary care pulmonary rehabilitation, multimorbidity and organisation of care
Year: 2017

Pulmonary hypertension and obstructive sleep apnea syndrome -Marmara Universitypediatric sleep laboratory experience
Source: Virtual Congress 2020 – Respiratory physiology and sleep: what is new?
Year: 2020


Clinical phenotypes in patients with concomitant obstructive sleep apnea and chronic obstructive pulmonary disease
Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD
Year: 2012


Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome
Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep
Year: 2009


Unrecognised hypertension in patients screened for obstructive sleep apnoea
Source: Eur Respir J 2005; 26: Suppl. 49, 40s
Year: 2005

Obstructive sleep apnea can cause pulmonary hypertension in the absence of lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 111s
Year: 2004

Hypertension and obstructive sleep apnoea
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006


Sleep hypoventilation in hypercapnic chronic obstructive pulmonary disease: prevalence and associated factors
Source: Eur Respir J 2003; 21: 977-984
Year: 2003



Efficacy of AUTO-CPAP titration in patients with obstructive sleep apnoea and chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 390s
Year: 2001

Resistant arterial hypertension and obstructive sleep apnea syndrome
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012

Cardiovascular and metabolic consequences of obstructive sleep apnoea
Source: Eur Respir J 2001; 18: Suppl. 33, 519s
Year: 2001

Autoantibody against NBL1 in obstructive sleep apnea patients with cardiovascular disease
Source: International Congress 2017 – New insights into the understanding of sleep and the consequences of sleep apnoea
Year: 2017



Prevalence of co-morbidities and clinical features in patients with obstructive sleep apnea and chronic obstructive pulmonary disease.
Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS)
Year: 2018